AKT-1981
A new screening tool for lower gastrointestinal malignancies has been developed known as the Faecal Immunochemical Test (FIT). The test is hoped to be an improvement on the previous stool tests as the FIT targets human haemoglobin.
The researchers would like to determine the specificity of the FIT test for colorectal cancer in a study involving 3000 participants aged 50 and above. All participants undergo a FIT and are subsequently evaluated with colonoscopy, which is considered the gold standard test.
Out of the 1200 participants who tested positive on the FIT, 800 were later confirmed to have colorectal cancer on colonoscopy.
On the other hand, out of the 1800 participants who tested negative on the FIT, 100 were later found to have colorectal cancer on colonoscopy.
What is the specificity of the FIT test for colorectal cancer in this study?